Portolan Capital Management LLC Has $8.35 Million Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Portolan Capital Management LLC grew its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 66.2% in the third quarter, Holdings Channel reports. The institutional investor owned 308,099 shares of the company’s stock after acquiring an additional 122,770 shares during the period. Portolan Capital Management LLC’s holdings in OrthoPediatrics were worth $8,353,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. Commonwealth Equity Services LLC grew its holdings in shares of OrthoPediatrics by 0.6% during the second quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock valued at $2,098,000 after buying an additional 420 shares during the last quarter. Triodos Investment Management BV grew its holdings in shares of OrthoPediatrics by 1.2% during the second quarter. Triodos Investment Management BV now owns 41,500 shares of the company’s stock valued at $1,194,000 after buying an additional 500 shares during the last quarter. Trust Point Inc. grew its holdings in shares of OrthoPediatrics by 10.0% during the third quarter. Trust Point Inc. now owns 8,532 shares of the company’s stock valued at $231,000 after buying an additional 773 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares during the last quarter. Finally, Quest Partners LLC purchased a new position in OrthoPediatrics during the second quarter worth about $34,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. JMP Securities restated a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th. Truist Financial cut their price target on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a report on Friday, November 8th.

OrthoPediatrics Stock Performance

Shares of KIDS stock opened at $26.18 on Wednesday. The firm has a market cap of $634.08 million, a price-to-earnings ratio of -21.28 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics Corp. has a 52 week low of $22.41 and a 52 week high of $36.23. The firm’s 50-day simple moving average is $25.99 and its two-hundred day simple moving average is $29.00.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.